Their results suggest that MUC1 deficiency in fibroblasts and lung cancer cells increases the EREG production that activates EGFR signaling to compensate for the MUC1 loss, thereby promoting the activation of the EGFR and AKT pathways during lung carcinogenesis. Here, EGFR is linked to lung carcinoma.